Skip to content

Price / sales at other companies

HCA Healthcare logo
HCA HealthcareHCA
1.4×+0.2×
National Healthcare logo
National HealthcareNHC
1.6×+0.6×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
0.6×+0.3×
Omnicell logo
OmnicellOMCL
1.2×-0.2×
ARD
Ardent Health PartnersARDT
0.2×-0.1×
Universal Health Services logo
Universal Health ServicesUHS
0.6×-0.1×

Other financials

Income statement

See full
Revenue$216.5M+2.2%
Gross profit$91.7M-22.5%
Operating income$81.3M+0.7%
Net income$46.8M+121%
EPS (diluted)$6.52+95.8%

Balance sheet

See full
Cash & equivalents$210.6M+149%
Total debt$348.9M+4.4%
Total equity$346.3M+75.7%
Total assets$957.3M+25.6%

Cash flow

See full
Operating cash flow$75.5M+48.2%
CapEx$1.2M+1,777%
Free cash flow$74.3M+46.0%

Valuation

See full
Market cap$1.02B+60.5%
Enterprise value$1.15B+30.8%
P/E10.5×+2.0×

Profitability

See full
Gross margin47.5%-1.3pp
Operating margin31.4%-2.2pp
Net margin11%-0.9pp
FCF margin30.6%+19.4pp

Returns & leverage

See full
Return on equity35.5%-21.2pp
Debt / equity-0.7×
Current ratio3.1×+0.9×

Where this comes from

Calculated from Nutex Health Inc.’s reported figures.

Based on the most recent quarter.

The official record: Nutex Health Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nutex Health Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nutex Health Inc.'s price / sales?
Nutex Health Inc. (NUTX) reported price / sales of 0.8× in Q1 2026.
How has Nutex Health Inc.'s price / sales changed year-over-year?
Nutex Health Inc.'s price / sales increased by 83.7% year-over-year, from 0.4× to 0.8×.
What is the long-term trend for Nutex Health Inc.'s price / sales?
Over 5 years (2020 to 2025), Nutex Health Inc.'s price / sales has grown at a -17.6% compound annual growth rate (CAGR), from 3.5× to 1.3×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.